SlideShare una empresa de Scribd logo
1 de 3
Chapters 17 & 18Chapters 17 & 18
Preventing & Treating
Substance Use
Disorders: Additional
Considerations
DSM-5: Brief OverviewDSM-5: Brief Overview
 DSM-5 released in 2013
 Overhaul for substance use disorders (substance-related
and addictive disorders)
 “Chemical” and “behavioral/process” addictions
 Criteria: impaired control, social impairment, risky use &
pharmacological criteria
 Mild, moderate & severe substance use disorder (SUD)
 Reaction to revisions
Harm ReductionHarm Reduction
Harm reduction: A set of practical
strategies that reduce negative
consequences of drug use
 Incorporates a spectrum of strategies from safer use to
abstinence
 Goals: Harm reduction strategies meet drug users "where
they're at," addressing conditions of use along with the use
itself
 Not about “permitting use”
 Societal benefits: public health, reducing deaths and crime

Más contenido relacionado

La actualidad más candente

Why Prescriber Education is Important
Why Prescriber Education is ImportantWhy Prescriber Education is Important
Why Prescriber Education is ImportantASAMPUBS
 
Adverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and ClassificationAdverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and ClassificationVenkateswaramurthy N
 
Polypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic managementPolypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic managementRosario Falanga
 
Severity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessmentSeverity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessmentDr. Ramesh Bhandari
 
2012 criterios beers
2012 criterios beers2012 criterios beers
2012 criterios beersSociosaniTec
 
Adverse event reporting
Adverse event reportingAdverse event reporting
Adverse event reportingBhushanSurana2
 
Medication adherence
Medication adherenceMedication adherence
Medication adherenceChanda Ranjan
 
Factors modifying drug action-2
Factors modifying drug action-2Factors modifying drug action-2
Factors modifying drug action-2Pravin Prasad
 

La actualidad más candente (14)

Why Prescriber Education is Important
Why Prescriber Education is ImportantWhy Prescriber Education is Important
Why Prescriber Education is Important
 
Adverse drug reactions
Adverse drug reactions Adverse drug reactions
Adverse drug reactions
 
Adverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and ClassificationAdverse Drug Reactions - Basics and Classification
Adverse Drug Reactions - Basics and Classification
 
Polypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic managementPolypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic management
 
Pharmacotherapy and adherence to beers criteria (providers)
Pharmacotherapy and adherence to beers criteria (providers)Pharmacotherapy and adherence to beers criteria (providers)
Pharmacotherapy and adherence to beers criteria (providers)
 
Beer's list 2015 update
Beer's list 2015 updateBeer's list 2015 update
Beer's list 2015 update
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Severity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessmentSeverity, seriousness, predictability and preventability assessment
Severity, seriousness, predictability and preventability assessment
 
2012 criterios beers
2012 criterios beers2012 criterios beers
2012 criterios beers
 
Handout adr
Handout adrHandout adr
Handout adr
 
Adverse event reporting
Adverse event reportingAdverse event reporting
Adverse event reporting
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Factors modifying drug action-2
Factors modifying drug action-2Factors modifying drug action-2
Factors modifying drug action-2
 

Destacado

US Mint Proof Sets: Collectors Desire
US Mint Proof Sets: Collectors DesireUS Mint Proof Sets: Collectors Desire
US Mint Proof Sets: Collectors DesireRaerev Services
 
Fashion online
Fashion onlineFashion online
Fashion onlinedav587f2la
 
Hart13 ppt ch03 2012 pt 1
Hart13 ppt ch03 2012 pt 1Hart13 ppt ch03 2012 pt 1
Hart13 ppt ch03 2012 pt 1JJJulieann
 
AODA Providers
AODA ProvidersAODA Providers
AODA ProvidersJJJulieann
 
Facebook power editor
Facebook power editorFacebook power editor
Facebook power editorAdam Guerguis
 
Issues Chapter 2
Issues Chapter 2Issues Chapter 2
Issues Chapter 2JJJulieann
 
Issues Chapter 1
Issues Chapter 1Issues Chapter 1
Issues Chapter 1JJJulieann
 
Leadership & organisational values
Leadership & organisational valuesLeadership & organisational values
Leadership & organisational valuesattractalagan
 
Social Media & Meetings Promotion Bootcamp
Social Media & Meetings Promotion BootcampSocial Media & Meetings Promotion Bootcamp
Social Media & Meetings Promotion BootcampDave Serino
 
How to #Win with Twitter in Travel
How to #Win with Twitter in TravelHow to #Win with Twitter in Travel
How to #Win with Twitter in TravelDave Serino
 

Destacado (14)

US Mint Proof Sets: Collectors Desire
US Mint Proof Sets: Collectors DesireUS Mint Proof Sets: Collectors Desire
US Mint Proof Sets: Collectors Desire
 
Fashion online
Fashion onlineFashion online
Fashion online
 
Content for Mindset
Content for MindsetContent for Mindset
Content for Mindset
 
Hart13 ppt ch03 2012 pt 1
Hart13 ppt ch03 2012 pt 1Hart13 ppt ch03 2012 pt 1
Hart13 ppt ch03 2012 pt 1
 
AODA Providers
AODA ProvidersAODA Providers
AODA Providers
 
Facebook power editor
Facebook power editorFacebook power editor
Facebook power editor
 
Issues Chapter 2
Issues Chapter 2Issues Chapter 2
Issues Chapter 2
 
Issues Chapter 1
Issues Chapter 1Issues Chapter 1
Issues Chapter 1
 
Chapter 8 14
Chapter 8 14Chapter 8 14
Chapter 8 14
 
Leadership & organisational values
Leadership & organisational valuesLeadership & organisational values
Leadership & organisational values
 
Social Media & Meetings Promotion Bootcamp
Social Media & Meetings Promotion BootcampSocial Media & Meetings Promotion Bootcamp
Social Media & Meetings Promotion Bootcamp
 
How to #Win with Twitter in Travel
How to #Win with Twitter in TravelHow to #Win with Twitter in Travel
How to #Win with Twitter in Travel
 
DD 2013
DD 2013DD 2013
DD 2013
 
The myth-of-Pandoras-box
The myth-of-Pandoras-boxThe myth-of-Pandoras-box
The myth-of-Pandoras-box
 

Similar a Chpts 17 & 18 Additional Considerations

introductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfintroductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfOgunsina1
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxAmeena Kadar
 
Toxicological risk assessment of chemicals
Toxicological risk assessment of chemicals  Toxicological risk assessment of chemicals
Toxicological risk assessment of chemicals Biplab Sikdar
 
Rheumatoid Arthritis Medications
Rheumatoid Arthritis MedicationsRheumatoid Arthritis Medications
Rheumatoid Arthritis MedicationsMark Moran
 
81-240-1 Chapter 06
81-240-1 Chapter 0681-240-1 Chapter 06
81-240-1 Chapter 06mpalaro
 
Risk reduction final-rev
Risk reduction final-revRisk reduction final-rev
Risk reduction final-revOPUNITE
 
08 ppt-substance abuse-final
08 ppt-substance abuse-final08 ppt-substance abuse-final
08 ppt-substance abuse-finaloliviaenny
 
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxAhmed Mshari
 
Write a essay on one of the following.docx
Write a essay on one of the following.docxWrite a essay on one of the following.docx
Write a essay on one of the following.docxwrite30
 
Medical solutions
Medical solutionsMedical solutions
Medical solutionsfitango
 
Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Bryan
 
Management of Adverse drug reactions
Management of Adverse drug reactionsManagement of Adverse drug reactions
Management of Adverse drug reactionsClinosolIndia
 
pharmaceutical_care_concept.pdf.Basic understanding of the Pharmaceutical car...
pharmaceutical_care_concept.pdf.Basic understanding of the Pharmaceutical car...pharmaceutical_care_concept.pdf.Basic understanding of the Pharmaceutical car...
pharmaceutical_care_concept.pdf.Basic understanding of the Pharmaceutical car...pumulopumulo376
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.pptShirazKhokhar1
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy ShaistaSumayya
 
Principles of De addiction Programme
Principles of De addiction ProgrammePrinciples of De addiction Programme
Principles of De addiction ProgrammeMayur Chaudhari
 
General Princples of Pharmacology_Approach to Learning Pharmacology
General Princples of Pharmacology_Approach to Learning PharmacologyGeneral Princples of Pharmacology_Approach to Learning Pharmacology
General Princples of Pharmacology_Approach to Learning PharmacologyImhotep Virtual Medical School
 

Similar a Chpts 17 & 18 Additional Considerations (20)

introductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfintroductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
 
Toxicological risk assessment of chemicals
Toxicological risk assessment of chemicals  Toxicological risk assessment of chemicals
Toxicological risk assessment of chemicals
 
Rheumatoid Arthritis Medications
Rheumatoid Arthritis MedicationsRheumatoid Arthritis Medications
Rheumatoid Arthritis Medications
 
81-240-1 Chapter 06
81-240-1 Chapter 0681-240-1 Chapter 06
81-240-1 Chapter 06
 
Risk reduction final-rev
Risk reduction final-revRisk reduction final-rev
Risk reduction final-rev
 
Eular recomendasi ra
Eular recomendasi   raEular recomendasi   ra
Eular recomendasi ra
 
08 ppt-substance abuse-final
08 ppt-substance abuse-final08 ppt-substance abuse-final
08 ppt-substance abuse-final
 
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
 
Write a essay on one of the following.docx
Write a essay on one of the following.docxWrite a essay on one of the following.docx
Write a essay on one of the following.docx
 
Medical solutions
Medical solutionsMedical solutions
Medical solutions
 
Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03
 
Management of Adverse drug reactions
Management of Adverse drug reactionsManagement of Adverse drug reactions
Management of Adverse drug reactions
 
pharmaceutical_care_concept.pdf.Basic understanding of the Pharmaceutical car...
pharmaceutical_care_concept.pdf.Basic understanding of the Pharmaceutical car...pharmaceutical_care_concept.pdf.Basic understanding of the Pharmaceutical car...
pharmaceutical_care_concept.pdf.Basic understanding of the Pharmaceutical car...
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
 
Integrated Treatment for Co-occurring disorders
Integrated Treatment for Co-occurring disordersIntegrated Treatment for Co-occurring disorders
Integrated Treatment for Co-occurring disorders
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy
 
Prevention
PreventionPrevention
Prevention
 
Principles of De addiction Programme
Principles of De addiction ProgrammePrinciples of De addiction Programme
Principles of De addiction Programme
 
General Princples of Pharmacology_Approach to Learning Pharmacology
General Princples of Pharmacology_Approach to Learning PharmacologyGeneral Princples of Pharmacology_Approach to Learning Pharmacology
General Princples of Pharmacology_Approach to Learning Pharmacology
 

Más de JJJulieann

Case presentationhybrid
Case presentationhybridCase presentationhybrid
Case presentationhybridJJJulieann
 
Chapter 8 a #3
Chapter 8 a #3Chapter 8 a #3
Chapter 8 a #3JJJulieann
 
Treatment system 13
Treatment system 13Treatment system 13
Treatment system 13JJJulieann
 
Bias & barriers to services
Bias & barriers to servicesBias & barriers to services
Bias & barriers to servicesJJJulieann
 
Hart13 ppt ch03 2012_pt 2
Hart13 ppt ch03 2012_pt 2Hart13 ppt ch03 2012_pt 2
Hart13 ppt ch03 2012_pt 2JJJulieann
 
Hart13 ppt ch03 2012
Hart13 ppt ch03 2012Hart13 ppt ch03 2012
Hart13 ppt ch03 2012JJJulieann
 
Culture wv pt 2 2012
Culture wv pt 2 2012Culture wv pt 2 2012
Culture wv pt 2 2012JJJulieann
 
Culture wv pt 1 2012
Culture wv pt 1 2012Culture wv pt 1 2012
Culture wv pt 1 2012JJJulieann
 
Client engagemen 12t
Client engagemen 12tClient engagemen 12t
Client engagemen 12tJJJulieann
 
Acculturation 12
Acculturation 12Acculturation 12
Acculturation 12JJJulieann
 
Culture & AODA Issues
Culture & AODA IssuesCulture & AODA Issues
Culture & AODA IssuesJJJulieann
 

Más de JJJulieann (17)

Case presentationhybrid
Case presentationhybridCase presentationhybrid
Case presentationhybrid
 
Chapter 8 a #3
Chapter 8 a #3Chapter 8 a #3
Chapter 8 a #3
 
Treatment system 13
Treatment system 13Treatment system 13
Treatment system 13
 
Bias & barriers to services
Bias & barriers to servicesBias & barriers to services
Bias & barriers to services
 
Chpt 8
Chpt 8Chpt 8
Chpt 8
 
Chpt 5 part 2
Chpt 5 part 2Chpt 5 part 2
Chpt 5 part 2
 
Chpt 4 part 2
Chpt 4 part 2Chpt 4 part 2
Chpt 4 part 2
 
Chpt 4 part 1
Chpt 4 part 1Chpt 4 part 1
Chpt 4 part 1
 
Hart13 ppt ch03 2012_pt 2
Hart13 ppt ch03 2012_pt 2Hart13 ppt ch03 2012_pt 2
Hart13 ppt ch03 2012_pt 2
 
Hart13 ppt ch03 2012
Hart13 ppt ch03 2012Hart13 ppt ch03 2012
Hart13 ppt ch03 2012
 
Culture wv pt 2 2012
Culture wv pt 2 2012Culture wv pt 2 2012
Culture wv pt 2 2012
 
Culture wv pt 1 2012
Culture wv pt 1 2012Culture wv pt 1 2012
Culture wv pt 1 2012
 
Client engagemen 12t
Client engagemen 12tClient engagemen 12t
Client engagemen 12t
 
CID 3 12
CID 3 12CID 3 12
CID 3 12
 
CID 4 12
CID 4 12CID 4 12
CID 4 12
 
Acculturation 12
Acculturation 12Acculturation 12
Acculturation 12
 
Culture & AODA Issues
Culture & AODA IssuesCulture & AODA Issues
Culture & AODA Issues
 

Último

PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesShubhangi Sonawane
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxNikitaBankoti2
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 

Último (20)

PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 

Chpts 17 & 18 Additional Considerations

  • 1. Chapters 17 & 18Chapters 17 & 18 Preventing & Treating Substance Use Disorders: Additional Considerations
  • 2. DSM-5: Brief OverviewDSM-5: Brief Overview  DSM-5 released in 2013  Overhaul for substance use disorders (substance-related and addictive disorders)  “Chemical” and “behavioral/process” addictions  Criteria: impaired control, social impairment, risky use & pharmacological criteria  Mild, moderate & severe substance use disorder (SUD)  Reaction to revisions
  • 3. Harm ReductionHarm Reduction Harm reduction: A set of practical strategies that reduce negative consequences of drug use  Incorporates a spectrum of strategies from safer use to abstinence  Goals: Harm reduction strategies meet drug users "where they're at," addressing conditions of use along with the use itself  Not about “permitting use”  Societal benefits: public health, reducing deaths and crime

Notas del editor

  1. Image source: Centers for Disease Control and Prevention (Image Ch17_15CDCSmokingPoster2) Image source: Corbis Images (Image Ch17_12SmokingRefusal) Image source: The McGraw-Hill Companies, Inc./John Flournoy, photographer (Image Ch17_20CommunityMural1) Image source: © image100 Ltd (Image Ch17_05Classroom3)